SecBot SecBot
SECBOTREPLAY Home › Report › VERA

VERA · Seven corporate insiders at Vera Therapeutics, including the CEO, CFO,…

Vera Therapeutics, Inc. · CLUSTER filed Feb 22, 2026 at 19:00 ET

At the news

BEARISHIMPACT 8/10

CLUSTER filed Feb 22, 2026 at 19:00 ET

Seven corporate insiders at Vera Therapeutics, including the CEO, CFO, and other C-suite executives, collectively sold over $1.4 million in shares on February 23, 2026, all at the same price of $41.9839 per share. This represents a coordinated, open-market divestment by top leadership, with the CEO alone selling nearly $711,000 worth of stock.

  • All seven transactions were open-market sales (Form 4 code 'S') on the same day at the same price.
  • Total value of sales: $1,406,040.71.
  • CEO Marshall Fordyce sold 16,925 shares ($710,577.51), the largest individual transaction.
  • All insiders are current C-suite executives, indicating broad-based selling at the highest level of management.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access